Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Karr, Robert W."'
Autor:
Molina, Hector, Holers, V. Michael, Li, Bin, Fang, Yi-Fu, Mariathasan, Sanjeev, Goellner, Joseph, Strauss-Schoenberger, Jena, Karr, Robert W., Chaplin, David D.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1996 Apr . 93(8), 3357-3361.
Externí odkaz:
https://www.jstor.org/stable/38964
Autor:
Pamela T. Manning, Ronald R. Hiebsch, Daniel S. Pereira, Benjamin J. Capoccia, Robyn J Puro, Michael J. Donio, Myriam N. Bouchlaka, William A. Frazier, Karr Robert W
Publikováno v:
Molecular Cancer Therapeutics. 19:835-846
Inhibitors of adaptive immune checkpoints have shown promise as cancer treatments. CD47 is an innate immune checkpoint receptor broadly expressed on normal tissues and overexpressed on many tumors. Binding of tumor CD47 to signal regulatory protein a
Autor:
Wucherpfennig, Kai W., Yu, Bei, Bhol, Kailash, Monos, Dimitri S., Argyris, Elias, Karr, Robert W., Ahmed, A. Razzaque, Strominger, Jack L.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1995 Dec 01. 92(25), 11935-11939.
Externí odkaz:
https://www.jstor.org/stable/2369014
Autor:
Gregersen, Peter K., Moriuchi, Tetsuya, Karr, Robert W., Obata, Fumiya, Moriuchi, Junko, Maccari, Joan, Goldberg, Donna, Winchester, Robert J., Silver, Jack
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1986 Dec 01. 83(23), 9149-9153.
Externí odkaz:
https://www.jstor.org/stable/28906
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Journal of Neuroimmunology 1999 96(2):144-147
Autor:
Robyn J Puro, Prabir Chakraborty, Daniel S. Pereira, Karr Robert W, Ronald R. Hiebsch, Vicki Sung, Pamela T. Manning, Alun Carter, Ben J Capoccia, W. Casey Wilson, Michael J. Donio, Myriam N. Bouchlaka
Publikováno v:
Blood. 132:4180-4180
Inhibitors of adaptive immune checkpoints have shown promise as cancer treatments. CD47 is an innate immune checkpoint receptor broadly expressed on normal tissues and over-expressed on several tumors. Binding of tumor CD47 to signal regulatory prote
Autor:
Robyn J Puro, Myriam N. Bouchlaka, Karr Robert W, K. J. M. Liu, Benjamin J. Capoccia, Ronald R. Hiebsch, Kathleen Crowley, Pamela T. Manning, Alun Carter, Michael J. Donio
Publikováno v:
Cancer Research. 78:1765-1765
CD47 is a cell surface glycoprotein that interacts with signal regulatory protein alpha (SIRPα) on macrophages and dendritic cells triggering a “don't eat me” signal that inhibits phagocytosis. Many tumors evade immune surveillance by overexpres
Autor:
Pankaj Bhargava, Alice Bexon, T.R. Jeffry Evans, Antoine Italiano, Pamela T. Manning, Philippa Graham, Stefan Symeonides, Karr Robert W, David Hinds, Ferry A.L.M. Eskens, Sanjay Chanda
Publikováno v:
Journal of Clinical Oncology. 35:TPS3109-TPS3109
TPS3109 Background: The cell surface protein CD47 is expressed or over-expressed on many tumor types. CD47 binds to signal regulatory protein alpha (SIRPα) on macrophages resulting in a “don’t eat me” signal that blocks host cell phagocytosis
Autor:
Wilson, W. Casey *, Bouchlaka, Myriam N *, Capoccia, Ben J *, Hiebsch, Ronald R *, Donio, Michael J *, Puro, Robyn J *, Carter, Alun J *, Chakraborty, Prabir *, Manning, Pamela T *, Karr, Robert W *, Sung, Vicki *, Pereira, Daniel S
Publikováno v:
In Blood 29 November 2018 132 Supplement 1:4180-4180